These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2617230)

  • 61. Auranofin-associated colitis and eosinophilia.
    Michet CJ; Rakela J; Luthra HS
    Mayo Clin Proc; 1987 Feb; 62(2):142-4. PubMed ID: 3807438
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Auranofin: a new drug for rheumatoid arthritis.
    Ann Intern Med; 1987 Apr; 106(4):631-2. PubMed ID: 3826966
    [No Abstract]   [Full Text] [Related]  

  • 63. The determination of neutrophil membrane fluidity in patients with hepatitis B: a fluorescence polarization study.
    Fan XG; Zhang Z
    APMIS; 1997 Apr; 105(4):309-12. PubMed ID: 9164474
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of auranofin and sulphasalazine therapy on circulating levels of interleukin 6 in rheumatoid arthritis patients.
    Crilly A; Capell HA; Watson J; Madhok R
    Clin Rheumatol; 1995 Sep; 14(5):561-5. PubMed ID: 8549096
    [No Abstract]   [Full Text] [Related]  

  • 65. [Auranofin (Ridaura). A new peroral agent containing gold used in the treatment of rheumatoid arthritis].
    Glennås A; Kvien TK; Rugstad HE
    Tidsskr Nor Laegeforen; 1986 Oct; 106(29):2438-40. PubMed ID: 3787612
    [No Abstract]   [Full Text] [Related]  

  • 66. Cholesterol modulation of membrane fluidity and ecto-nucleotide triphosphatase activity in human normal and CLL lymphocytes.
    Deliconstantinos G; Daefler S; Krueger GR
    Anticancer Res; 1987; 7(3 Pt B):347-52. PubMed ID: 2957950
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
    Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
    Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin.
    Coughlan RJ; Richter MB; Panayi GS
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():25-32. PubMed ID: 6432410
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Clin Rheumatol; 1990 Sep; 9(3):356-61. PubMed ID: 2261735
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Membrane fluidity measured by fluorescence polarization using an EPICS V cell sorter.
    Fox MH; Delohery TM
    Cytometry; 1987 Jan; 8(1):20-5. PubMed ID: 3803094
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of cytoplasmic lipids in altering diphenylhexatriene fluorescence polarization in malignant cells.
    Spiegel RJ; Magrath IT; Shutta JA
    Cancer Res; 1981 Feb; 41(2):452-8. PubMed ID: 7448790
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of exposure to poultry chemical decontaminants on the membrane fluidity of Listeria monocytogenes and Salmonella enterica strains.
    Alonso-Hernando A; Alonso-Calleja C; Capita R
    Int J Food Microbiol; 2010 Feb; 137(2-3):130-6. PubMed ID: 20056288
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Alteration of erythrocyte membrane fluidity by heavy metal cations.
    Amoruso MA; Witz G; Goldstein BD
    Toxicol Ind Health; 1987 Mar; 3(1):135-44. PubMed ID: 3590203
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Spontaneous lymphocyte activity in rheumatoid arthritis in a longitudinal study in relation to gold therapy.
    Froebel KS; Lewis D; Dickson R; Sturrock RD
    Clin Rheumatol; 1985 Sep; 4(3):301-7. PubMed ID: 3933897
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An open trial of auranofin (oral gold preparation) in rheumatoid arthritis.
    Malaviya AN; Kabra KR; Kumar A
    J Assoc Physicians India; 1986 Sep; 34(9):625-7. PubMed ID: 3539909
    [No Abstract]   [Full Text] [Related]  

  • 76. Decreased membrane "fluidity" of T lymphocytes from untreated patients with Hodgkin's disease.
    Aleksijevic A; Cremel G; Mutet C; Giron C; Hubert P; Waksman A; Falkenrodt A; Oberling F; Mayer S; Lang JM
    Leuk Res; 1986; 10(12):1477-84. PubMed ID: 3491936
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The cost effectiveness of auranofin: results of a randomized clinical trial.
    Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED
    J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Oral gold for rheumatoid arthritis].
    Wigler I; Caspi D; Lorber M; Sukenik S; Green L; Fishel B; Tishler M; Segal R; Horovitz J; Yaron M
    Harefuah; 1988 Jun; 114(11):529-33. PubMed ID: 3396988
    [No Abstract]   [Full Text] [Related]  

  • 79. [Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis].
    Atakhodzhaeva ZA; Sigidin IaA
    Ter Arkh; 1987; 59(12):30-3. PubMed ID: 3328906
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.